Ceftriaxone-related fatal hemolysis in an adolescent with perinatally acquired human immunodeficiency virus infection.

Moallem, H J; Garratty, G; Wakeham, M; Dial, S; Oligario, A; Gondi, A; Rao, S P; Fikrig, S · J Pediatr · 1998

case_report · Level V

Where this comes from

Abstract

A 14-year-old girl with perinatally acquired human immunodeficiency virus infection had fatal intravascular hemolysis after intravenous administration of ceftriaxone. Laboratory studies confirmed the presence of an antibody against ceftriaxone in the serum and on the patient's red blood cells. No evidence of sepsis, glucose-6-phosphate dehydrogenase deficiency or anaphylaxis was found.

Medical subject headings